http://centennialmining.com/, page-356

First 356 Last

Share
Profile

Follow
meric

1,591 Posts.

42

12/04/18

11:42

Post #: 32404537
Share

Originally posted by precis ↑

I'd be cautious. From the Dec quarterly (14/2/2018) the estimated expenditure for March quarter was $7.9 million. Positively impacting on this would be reduced production and wages costs due to the closure of the mill while the new gearbox was fitted, and the trucking of some ore from Union Hill (5k distance) instead of A1 (300 k distance). No doubt expenditure could be contained to be less than $7.5 million leaving a profit of $0.5 million. Execs though have a habit of spending as the money flows though in this case, there is a need to have $2.5 mil in the bank pretty soon. The good news is the latest pour figures. Even at the low end of 406 oz/week (based on the average for the last 7 weeks) x 13 = 5278 oz for the quarter, x $1700 = $9 mil. Can easily see a $1.5 mil profit for the next quarter, added to end Dec cash ($600,000) and profit for March quarter I've estimated at $500,000 as above, and the debt is pretty much gone. So in the March quarterly, I'm looking for cost containment (sub $7.5 mil) and cash in hand of $1 mil +, along with a notice of production figures averaging greater than 406 oz/week for the start of the June quarter. Ideally accompanying this would be some increase in grade being milled since this has been a company goal on which future success rests.

Expand

It was not as good as I hoped and I sold ~10% today. All in on next quarter...

CTL Price at posting: 1.3¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

RCE

Recce's R327 found effective against E.coli during clinical trial